Emerging use of pulmonary artery and cardiac pressure sensing technology in the management of worsening heart failure events
- PMID: 40343668
- PMCID: PMC12296964
- DOI: 10.1007/s10741-025-10513-2
Emerging use of pulmonary artery and cardiac pressure sensing technology in the management of worsening heart failure events
Erratum in
-
Correction to: Emerging use of pulmonary artery and cardiac pressure sensing technology in the management of worsening heart failure events.Heart Fail Rev. 2025 Sep;30(5):1139. doi: 10.1007/s10741-025-10534-x. Epub 2025 Jun 3. Heart Fail Rev. 2025. PMID: 40459813 Free PMC article. No abstract available.
Abstract
Unplanned admissions for worsening heart failure (WHF) are the largest resource cost in heart failure (HF) management. Despite advances in pharmacological agents and interventional therapy, HF remains a global epidemic. One crucial-and costly-gap in HF management is the inability to obtain objective information to identify and quantify congestion and personalize treatment plans to effectively manage WHF events without resorting to expensive, invasive methods. Although the causes of WHF are varied and complex, the universal effect of HF decompensation is the significant decline in quality of life due to symptoms of hypervolemic congestion and the resultant reduction in cardiac output, which can be quantified via increased pulmonary venous congestion due to high intracardiac filling pressures. Accessible and reliable markers of congestion could more precisely quantify the severity of WHF events and stabilize patients earlier by interrupting and reversing this process with timely introduction or modification of evidence-based treatments. Pulmonary artery and cardiac pressure sensing tools have gained evidential credence and increased clinical uptake in recent years for the prevention and treatment of WHF, as studies of implantable hemodynamic devices have iteratively and reliably demonstrated substantial reductions in WHF events. Recent advances in sensing technologies have ranged from single-parameter invasive pulmonary artery monitors to completely non-invasive multi-parameter devices incorporating multi-sensor concept technologies aided by machine learning or artificial intelligence, although many remain investigational. This review aims to evaluate the potential for novel pulmonary artery and cardiac pressure sensing technology to reshape the management of WHF from within the hospitalized and ambulatory care environments.
Keywords: Non-invasive devices; Pulmonary artery and cardiac pressure sensing; Worsening heart failure.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912. Health Technol Assess. 2024. PMID: 39186036 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009. Health Technol Assess. 2024. PMID: 39189844 Free PMC article.
-
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558. Health Technol Assess. 2025. PMID: 40418146 Clinical Trial.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
References
-
- Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, et al (2023)Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail 29. 10.1016/j.cardfail.2023.07.006.
-
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) AHA/ACC/HFSA guideline for the management of heart failure. J Card Fail 2022:28. 10.1016/j.cardfail.2022.02.010
-
- Khan MS, Sreenivasan J, Lateef N, Abougergi MS, Greene SJ, Ahmad T, et al (2021) Trends in 30- and 90-day readmission rates for heart failure. Circ Heart Fail 14. 10.1161/CIRCHEARTFAILURE.121.008335. - PubMed
-
- Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M et al (2014) The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63:1123–1133. 10.1016/j.jacc.2013.11.053 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous